Jm. Grosbois et al., VALUE OF CEM CO2 IN THE NEGATIVE DIAGNOSI S OF ACUTE PULMONARY EMBOLUS IN CASES OF CHRONIC BRONCHOPNEUMOPATHIC OBSTRUCTIONS, Revue des maladies respiratoires, 12(1), 1995, pp. 35-41
The aim of this prospective study was to analyse the contribution of t
he measurement of alveolar arterial gradients of CO2 during forced exp
iration in the diagnosis of pulmonary emboli occurring in chronic airf
low obstruction (COPD) as a result of smoking. The study was carried o
ut on 178 patients: Group 1: 54 subjects without emboli (14 controls,
33 COPD and 7 patients with chest pain); Group 2: 72 patients with pro
ved emboli (49 non COPD, 23 COPD); Group 3: 52 patients COPD presentin
g with varied non-embolic broncho-pulmonary pathology (pneumonia, bron
chospasm, pulmonary oedema, bronchial neoplasm). The diagnosis of pulm
onary emboli was confirmed by scintigraphy in patients with non COPD o
r angiography (in patients with COPD). The maximal fraction of CO2 was
measured using a capnologue during a forced expiration which was long
and prolonged until residual volume was achieved. The PaCO2 was measu
red simultaneously by an analysis of arterial blood gases. The D index
was calculated according to the formula [(PaCO2 - PEM CO2)/PaCO2] x 1
00. The D index was significantly lower in Group 1 (3.42+/-3,8% p <0,0
001) than in Group 2 (20.8+/-10%) and Group 3 (27.6+/-11.7%) (not sign
ificant between Groups 2 and 3). in patients with COPD the specificity
and sensitivity and the predicted positive and negative value were 10
0% for a D limit of 7%. In COPD patients these values were respectivel
y 82, 95, 75 and 96% for a D limit of 7%; on the other hand for a D be
low 5% the values were 60, 100, 64 and 100% respectively. In conclusio
n a gradient below 5% was a useful negative argument against the diagn
osis of pulmonary emboli in COPD patients and enabled invasive examina
tions to be avoided.